Gene · 51548
Papers4,574
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 4,574
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Triclabendazole inhibits PKM2 nuclear localization and glycolysis by enhancing HDAC6-mediated deacetylation in lung cancer. | J Transl Med | 2025 | 40993625 | PubTator, text mining | PubMed |
| Specific Binding Modes of the SIRT6 C-Terminal Domain to the Nucleosome Core Particle Influence DNA Unwrapping and H3K27 Accessibility. | J Phys Chem B | 2025 | 40990443 | PubTator, text mining | PubMed |
| The m6A modification in cancer: roles, implications, and its potential in therapy. | Mol Biomed | 2025 | 40986143 | PubTator, text mining | PubMed |
| Dioscin initiates dual roles in bladder cancer progression via miR-195-5p/FASN/SLC3A2 axis-mediated cell death mechanisms. | Transl Oncol | 2025 | 40961580 | PubTator, text mining | PubMed |
| Skinspan: A Holistic Roadmap for Extending Skin Longevity With Evidence-Based Interventions. | J Cosmet Dermatol | 2025 | 40913411 | PubTator, text mining | PubMed |
| Delactylation of H3K9 by Sirtuin6 inhibits MGMT transcription and reverses temozolomide resistance in glioblastoma. | Int J Biol Macromol | 2025 | 40907925 | PubTator, text mining | PubMed |
Reorganization of Mitochondrial Function and Architecture in Response to Plant-Derived Alkaloids: Anatabine, Anabasine, and Nicotine, Investigated in SH-SY5Y Cells and in a Cellular Model of Parkinson's Disease. | CNS Neurosci Ther | 2025 | 40905146 | PubTator, text mining | PubMed |
| The multi-dimensional regulatory mechanism of Sirt6 in heart health: From cell death pathways to targeted therapy for cardiovascular diseases. | Biochem Biophys Res Commun | 2025 | 40902544 | PubTator, text mining | PubMed |
| Interrogating the regulatory epigenome of cellular senescence. | Cell Mol Life Sci | 2025 | 40886198 | PubTator, text mining | PubMed |
| Clinical application of radiofrequency technology in the treatment of facial skin wrinkles and laxity. | World J Clin Cases | 2025 | 40881233 | PubTator, text mining | PubMed |
| Genetic and Phenotypic Variability in Siblings With Friedreich Ataxia. | Neurol Genet | 2025 | 40880907 | PubTator, text mining | PubMed |
| Regulatory Dynamics of Nrf2 With Sirtuins in the Brain: Exploring Cellular Metabolism, Synaptic Plasticity, and Defense Mechanisms. | J Neurochem | 2025 | 40878635 | PubTator, text mining | PubMed |
| Cellular Models of Aging and Senescence. | Cells | 2025 | 40862757 | PubTator, text mining | PubMed |
| Oxidative stress-induced ZEB1 acetylation drives a hybrid epithelial-mesenchymal phenotype and promotes lung metastasis in triple-negative breast cancer. | Redox Biol | 2025 | 40850192 | PubTator, text mining | PubMed |
| Emerging dual role of ferroptosis in lung cancer (Review). | Oncol Rep | 2025 | 40849820 | PubTator, text mining | PubMed |
| NAD+-dependent Sirt6 is a key regulator involved in telomere shortening of in vitro-cultured preimplantation embryos. | Commun Biol | 2025 | 40849514 | PubTator, text mining | PubMed |
| Mechanisms Underlying Muscle-Related Diseases and Aging: Insights into Pathophysiology and Therapeutic Strategies. | Muscles | 2025 | 40843913 | PubTator, text mining | PubMed |
| SIRT6 Is a Key Regulator of Pancreatic β-Cell Survival and Function During Aging. | Diabetes | 2025 | 40839369 | PubTator, text mining | PubMed |
| Sirtuin 3 in diabetic kidney disease: mechanisms and pharmacotherapy. | Ren Fail | 2025 | 40827435 | PubTator, text mining | PubMed |
| SIRT6 Lysine-Demyristoylates ATF2 to Ameliorate Vascular Injury via PRKCD/VE-Cadherin Pathway Regulating Vascular Endothelial Barrier. | Adv Sci (Weinh) | 2025 | 40810740 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51548/papers?page=10